Alpha 2.0
Login Register
» Articles » PMID: 33304621

Preliminary Results of the Micro-Elimination Project of Hepatitis C in a Disadvantaged Town in South-West of Romania-Orşova

Overview
Journal Curr Health Sci J
Specialty General Medicine
Date 2020 Dec 11
PMID 33304621
Citations 4
Authors
Anca Elena Butaru
Irina Paula Doica
Dan Ionut Gheonea
Ion Rogoveanu
Mircea Diculescu
Carmen Nicoleta Oancea
Affiliations
Soon will be listed here.
Abstract

Materials And Methods: In the first two weeks after the start of the study, 320 patients with detectable risk factors for HCV were tested using rapid tests, in a southwestern city of Romania, Orşova, with the participation of four doctors, via Family Medicine Offices.

Results: As a percentage, the amount of detection based on rapid tests was 2.5%, the positive results have apparently been achieved exclusively among female subjects. All patients have been informed about the result and included in the diagnostic trial, where they were fully evaluated to determine if they were eligible for therapy.

Conclusions: Population screening contributes to the diagnosis and elimination of an underdiagnosed pathology, in a disadvantaged area with limited access to medical care. The positive feedback that has been received in just a few weeks after its beginning, once again has motivated to emphasis the population screening, with real considerations on the possibility of expanding this program on a large scale.

Citing Articles

Resource Management through Artificial Intelligence in Screening Programs-Key for the Successful Elimination of Hepatitis C.

Butaru A, Mamuleanu M, Streba C, Doica I, Diculescu M, Gheonea D Diagnostics (Basel). 2022; 12(2).

PMID: 35204437 PMC: 8871056. DOI: 10.3390/diagnostics12020346.

Micro-Elimination: Updated Pathway to Global Elimination of Hepatitis C in Small Communities and Industrial Settings during the COVID 19 Pandemic.

Butaru A, Gheonea D, Rogoveanu I, Diculescu M, Boicea A, Bunescu M J Clin Med. 2021; 10(21).

PMID: 34768496 PMC: 8584569. DOI: 10.3390/jcm10214976.

Development and Validation of a Questionnaire to Measure Medication Adherence to Direct-Acting Agents in Patients with Hepatitis C.

Turcu-Stiolica A, Doica I, Ungureanu B, Rogoveanu I, Florescu D, Subtirelu M Pharmaceutics. 2021; 13(10).

PMID: 34683976 PMC: 8540644. DOI: 10.3390/pharmaceutics13101683.

Telemedicine Chronic Viral Hepatitis C Treatment during the Lockdown Period in Romania: A Pilot Study.

Doica I, Florescu D, Oancea C, Turcu-Stiolica A, Subtirelu M, Dumitra G Int J Environ Res Public Health. 2021; 18(7).

PMID: 33916226 PMC: 8037937. DOI: 10.3390/ijerph18073694.

References
1.
Gheorghe L, Csiki I, Iacob S, Gheorghe C, Smira G, Regep L . The prevalence and risk factors of hepatitis C virus infection in adult population in Romania: a nationwide survey 2006 - 2008. J Gastrointestin Liver Dis. 2010; 19(4):373-9. View
2.
Cox A, El-Sayed M, Kao J, Lazarus J, Lemoine M, Lok A . Progress towards elimination goals for viral hepatitis. Nat Rev Gastroenterol Hepatol. 2020; 17(9):533-542. PMC: 7376316. DOI: 10.1038/s41575-020-0332-6. View
3.
Popping S, Bade D, Boucher C, van der Valk M, El-Sayed M, Sigurour O . The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals. J Virus Erad. 2019; 5(1):60-66. PMC: 6362901. View
4.
Elgharably A, Gomaa A, Crossey M, Norsworthy P, Waked I, Taylor-Robinson S . Hepatitis C in Egypt - past, present, and future. Int J Gen Med. 2017; 10:1-6. PMC: 5191841. DOI: 10.2147/IJGM.S119301. View
5.
Razavi H, Waked I, Sarrazin C, Myers R, Idilman R, Calinas F . The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm. J Viral Hepat. 2014; 21 Suppl 1:34-59. DOI: 10.1111/jvh.12248. View